Cancer Research Institute

From Wikipedia, the free encyclopedia
Jump to: navigation, search

The Cancer Research Institute (CRI) is a US non-profit organization funding cancer research and based in New York City. They were founded in 1953 to develop immunologically-based treatments for cancer, and despite their name are a funding body for research rather than a research institute themselves, working with other institutes and organizations. It was founded by Helen Coley Nauts and Oliver R. Grace with a $2,000 grant from Nelson Rockefeller. CRI was created in honor of Nauts' father, William Coley (1862–1936), an American orthopedic surgeon and a pioneer of cancer immunotherapy. Like Dr. Coley, the Institute focuses on immunological treatments for cancer, rather than traditional treatments, such as chemotherapy and surgery.

The organization offers research grants to students, postdoctoral fellows, and investigators at medical research institutions throughout the world. It also funds clinical trials testing promising immunotherapies in a variety of cancer types and convenes scientific conferences for tumor immunologists. In the fiscal year to June 2014 the CRI reported income of $27.5 million and spending of $25 million: $18 million on research, $4 million on education, and $3 million on fundraising and administration.[1]

In June 2014, CRI launched its "I'm the Answer to Cancer" patient and caregiver education campaign, featured on the website Annually in June, the organization sponsors Cancer Immunotherapy Month, an awareness and fund raising campaign dedicated to educating the public about the potential of immunotherapy to revolutionize cancer treatment.

In June 2015, CRI will host the inaugural New York Ride to Conquer Cancer, a 2-day, 150+ mile cycling ride through scenic New York to raise funds for cancer research. Details of The Ride are available at


The institute makes a number of awards for excellence in the field of cancer research. [2]

William B. Coley Award

The William B. Coley Award is given annually to one or more scientists for outstanding achievements in the field of basic immunology and cancer immunology. Awardees receive an honorary medal and $5,000 prize. It is named for the pioneer of cancer immunotherapy, William B. Coley.

Lloyd J. Old Award

The Lloyd J. Old Award in Cancer Immunology recognizes an active scientist whose outstanding and innovative research in cancer immunology has had a far-reaching impact on the cancer field. It is named after Lloyd J. Old, one of the founders and standard-bearers of the field of cancer immunology.

Frederick W. Alt Award

The Frederick W. Alt Award recognizes outstanding success in academia or industry for research that may have a potentially major impact on immunology. It is named in honor of geneticist Frederick W. Alt.

Other awards are the Oliver R Grace Award and the Helen Coley Nauts Award.


  1. ^ CRI Annual Report 2014, page 45, accessed 6 February 2015
  2. ^ "Our Strategy & Impact". Cancer Research Institute. Retrieved 10 December 2014.